The Nuclear Regulatory Commission approved Framatome’s license amendment Wednesday to fabricate higher-enriched uranium at the company’s Richland, Wash.-based facility, which is adjacent to the Department of Energy’s Hanford Site. This regulatory approval allows for Framatome to enrich uranium higher than 5% specifically at the Richland facility, which has been in operation since 1969. Manufacturing at the site is scheduled to begin in 2027, ac…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.